全文获取类型
收费全文 | 5019篇 |
免费 | 634篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 121篇 |
妇产科学 | 160篇 |
基础医学 | 740篇 |
口腔科学 | 287篇 |
临床医学 | 651篇 |
内科学 | 888篇 |
皮肤病学 | 57篇 |
神经病学 | 434篇 |
特种医学 | 109篇 |
外科学 | 677篇 |
综合类 | 115篇 |
一般理论 | 9篇 |
预防医学 | 588篇 |
眼科学 | 58篇 |
药学 | 344篇 |
中国医学 | 1篇 |
肿瘤学 | 372篇 |
出版年
2023年 | 40篇 |
2022年 | 26篇 |
2021年 | 168篇 |
2020年 | 101篇 |
2019年 | 191篇 |
2018年 | 174篇 |
2017年 | 149篇 |
2016年 | 129篇 |
2015年 | 144篇 |
2014年 | 158篇 |
2013年 | 185篇 |
2012年 | 274篇 |
2011年 | 264篇 |
2010年 | 147篇 |
2009年 | 121篇 |
2008年 | 222篇 |
2007年 | 218篇 |
2006年 | 201篇 |
2005年 | 221篇 |
2004年 | 196篇 |
2003年 | 170篇 |
2002年 | 175篇 |
2001年 | 161篇 |
2000年 | 137篇 |
1999年 | 159篇 |
1998年 | 52篇 |
1997年 | 44篇 |
1996年 | 60篇 |
1995年 | 53篇 |
1994年 | 39篇 |
1993年 | 38篇 |
1992年 | 121篇 |
1991年 | 101篇 |
1990年 | 89篇 |
1989年 | 104篇 |
1988年 | 85篇 |
1987年 | 82篇 |
1986年 | 61篇 |
1985年 | 62篇 |
1984年 | 41篇 |
1983年 | 42篇 |
1982年 | 25篇 |
1981年 | 21篇 |
1979年 | 44篇 |
1978年 | 33篇 |
1977年 | 37篇 |
1976年 | 29篇 |
1975年 | 30篇 |
1971年 | 23篇 |
1970年 | 29篇 |
排序方式: 共有5662条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
Zumel-Marne Angela Kundi Michael Castaño-Vinyals Gemma Alguacil Juan Petridou Eleni Th Georgakis Marios K. Morales-Suárez-Varela Maria Sadetzki Siegal Piro Sara Nagrani Rajini Filippini Graziella Hutter Hans-Peter Dikshit Rajesh Woehrer Adelheid Maule Milena Weinmann Tobias Krewski Daniel ′t Mannetje Andrea Momoli Franco Lacour Brigitte Mattioli Stefano Spinelli John J. Ritvo Paul Remen Thomas Kojimahara Noriko Eng Amanda Thurston Angela Lim Hyungryul Ha Mina Yamaguchi Naohito Mohipp Charmaine Bouka Evdoxia Eastman Chelsea Vermeulen Roel Kromhout Hans Cardis Elisabeth 《Journal of neuro-oncology》2020,147(2):427-440
Journal of Neuro-Oncology - We used data from MOBI-Kids, a 14-country international collaborative case–control study of brain tumors (BTs), to study clinical characteristics of the tumors in... 相似文献
5.
Colin Holbrook Marco Iacoboni Chelsea Gordon Shannon Proksch Ramesh Balasubramaniam 《Social cognitive and affective neuroscience》2020,15(12):1350
Research indicates that the posterior medial frontal cortex (pMFC) functions as a ‘neural alarm’ complex broadly involved in registering threats and helping to muster relevant responses. Holbrook and colleagues investigated whether pMFC similarly mediates ideological threat responses, finding that downregulating pMFC via transcranial magnetic stimulation (TMS) caused (i) less avowed religious belief despite being reminded of death and (ii) less group bias despite encountering a sharp critique of the national in-group. While suggestive, these findings were limited by the absence of a non-threat comparison condition and reliance on sham rather than control TMS. Here, in a pre-registered replication and extension, we downregulated pMFC or a control region (MT/V5) and then primed participants with either a reminder of death or a threat-neutral topic. As mentioned previously, participants reminded of death reported less religious belief when pMFC was downregulated. No such effect of pMFC downregulation was observed in the neutral condition, consistent with construing pMFC as monitoring for salient threats (e.g. death) and helping to recruit ideological responses (e.g. enhanced religious belief). However, no effect of downregulating pMFC on group bias was observed, possibly due to reliance on a collegiate in-group framing rather than a national framing as in the prior study. 相似文献
6.
Martina A. Steurer Jean Costello Rebecca J. Baer Scott P. Oltman Sky K. Feuer Tania Pacheco-Werner Elizabeth Rogers Marta M. Jankowska Jessica Block Molly McCarthy Matthew S. Pantell Christina Chambers Kelli K. Ryckman Laura L. Jelliffe-Pawlowski 《Paediatric and perinatal epidemiology》2020,34(2):130-138
7.
Philip J. Lupo Ruth E. Luna-Gierke Tiffany M. Chambers Björn Tavelin Michael E. Scheurer Beatrice Melin Karin Papworth 《International journal of cancer. Journal international du cancer》2020,146(3):791-802
Perinatal factors have been associated with soft tissue sarcomas (STS) in case-control studies. However, (i) the contributions of factors including fetal growth remain unknown, ( ii ) these factors have not been examined in cohort studies and (iii) few assessments have evaluated risk in specific STS subtypes. We sought to identify the role of perinatal and familial factors on the risk of STS in a large population-based birth cohort. We identified 4,023,436 individuals in the Swedish Birth Registry born during 1973–2012. Subjects were linked to the Swedish Cancer Registry, where incident STS cases were identified. We evaluated perinatal and familial factors obtained from Statistics Sweden, including fetal growth, gestational age, and presence of a congenital malformation. Poisson regression was used to estimate incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for associations between perinatal factors and STS overall, as well as by common subtypes. There were 673 individuals diagnosed with STS in 77.5 million person-years of follow-up. Having a congenital malformation was associated with STS (IRR = 1.70, 95% CI: 1.23–2.35). This association was stronger (IRR = 2.90, 95% CI: 1.25–6.71) in recent years (2000–2012). Low fetal growth was also associated with STS during the same time period (IRR = 1.86, 95% CI: 1.05–3.29). Being born preterm was associated with rhabdomyosarcoma (IRR = 1.74, 95% CI: 1.08–2.79). In our cohort study, those with congenital malformations and other adverse birth outcomes were more likely to develop a STS compared to their unaffected contemporaries. These associations may point to disrupted developmental pathways and genetic factors influencing the risk of STS. 相似文献
8.
9.
Renee Heffron Sharon L. Achilles Laneta J. Dorflinger Janet P. Hapgood James Kiarie Chelsea B. Polis Petrus S. Steyn 《Contraception》2019,99(4):199-204
Access to safe and effective contraceptive choices is a reproductive right and contributes tremendously to improvements in maternal and child health. Progestin-only injectables, particularly intramuscularly injected depot medroxyprogesterone acetate (DMPA-IM), have received increased attention given findings suggesting a potential association with increased HIV risk. For women at high risk of HIV, the World Health Organization's Medical eligibility criteria for contraceptive use currently aggregate recommendations for all progestin-only injectables, including DMPA-IM, subcutaneously injected DMPA (DMPA-SC) and intramuscularly injected norethindrone/ norethisterone enanthate (NET-EN), except in the case of some drug interactions. We considered whether published data indicate differences or similarities between these injectables relevant to risk of acquiring HIV. In vitro data confirm different biological activities of these distinct progestins, including that MPA, and not NET, binds and activates the glucocorticoid receptor resulting in different biological effects relevant to immune function. Limited clinical data suggest changes in immunologic activity following DMPA-IM and NET-EN initiation, but interstudy variation and study design differences diminish ability to determine clinical relevance and the degree to which DMPA-IM and NET-EN could act differentially. The highest-quality epidemiologic studies suggest a potential 40% increase in HIV incidence in users of DMPA-IM relative to women not using hormonal contraception but no significant increase in risk in users of NET-EN. In our opinion, most of the available biologic activity and epidemiologic data indicate that DMPA and NET-EN are likely to act differently, and data remain too limited to evaluate differences between DMPA-IM and DMPA-SC. 相似文献
10.
Grace G. Wong Vincent Ha Michael P. Chu Deonne Dersch-Mills Sunita Ghosh Carole R. Chambers Michael B. Sawyer 《Clinical colorectal cancer》2019,18(1):72-79